查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1453953

到 2030 年的电子临床解决方案市场预测：按产品、交付型态、临床试验阶段、用户设备、最终用户和地区进行的全球分析

eClinical Solutions Market Forecasts to 2030 - Global Analysis By Product, Delivery Mode, Clinical Trial Phase, User Device, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球电子临床解决方案市场规模将达到 95 亿美元，预计到 2030 年将达到 256 亿美元，预测期内复合年增长率为 15.2%。

电子临床解决方案旨在彻底改变临床研究。为了更快地治疗患者，临床管理组织正在努力提高临床研究资料的有效性、效率和可近性。开发电子临床解决方案的目标是识别临床研究资料中的痛点，提供创新的解决方案，让临床试验资料更容易取得、更有价值。它还旨在简化临床研究领域的标准化、报告和功能。

根据 ClinicalTrials.gov 统计，截至 2023 年 3 月，已有 221 个国家註册了 443,933 项研究，其中 342,633 项为干预研究，99,578 项为观察性研究。根据美国卫生研究院2023年3月更新的资料，2022年美国用于临床试验和推广的研究支出预计为66亿美元，2023年将增加至68亿美元，预计还会增加。

扩大电子健康记录的采用

EHR 集中患者健康资讯并提供可用于临床研究目的的有价值的资料。与 EHR 系统无缝整合的 eClinical 解决方案可在整个临床试验生命週期中实现高效的资料收集、患者招募和监控。透过弥合临床护理和研究之间的差距，这些整合解决方案有助于接触患者群体，加快研究启动时间，并提高临床试验资料的准确性和完整性。此外，还可以从 EHR 中提取结构化资料，从而提高资料品质并减少手动资料输入错误。

实施成本高

实施电子临床解决方案需要大量的前期投资，包括软体许可证、硬体基础设施、客製化和员工培训。对于预算有限的组织来说，这些成本过高，阻碍了他们实施电子临床技术。持续的维护、支援和订阅费用进一步增加了总拥有成本，加剧了长期的财务负担。然而，电子临床解决方案的复杂性以及实施和客製化它们所需的专业知识也导致成本上升。

临床试验全球化进展

临床试验的日益全球化是电子临床解决方案市场的主要驱动因素。随着临床试验扩大到涵盖世界各地的广泛患者群体和医疗保健环境，电子临床解决方案提供了一个统一的资料收集、管理和分析平台，可供世界各地的临床试验场所和场所使用，促进无缝相关人员。此外，这些解决方案还可以即时存取试验资料，并简化国际团队之间的沟通和决策流程。

复杂的监管环境

临床试验受到各监管机构的严格监管，例如美国FDA（食品药物管理局）和欧洲EMA（欧洲药品管理局）。遵守这些法规，包括资料隐私、安全、报告标准等，需要大量的资源、专业知识和时间。遵守不断变化的监管要求为电子临床解决方案的实施和操作带来了复杂性。

COVID-19 的影响：

由于临床试验因面对面互动的封锁和限製而面临中断，对 eClinical 平台提供的远端监控、虚拟测试和数位数位资料撷取解决方案的需求增加。此次疫情凸显了即时资料存取和分析的重要性，推动了电子临床解决方案的采用，以加快决策和监管合规性。此类中断包括由于製造延迟或中断而导致必要的硬体和软体组件的采购延迟。此外，COVID-19 的爆发凸显了供应链的脆弱性，促使企业重新思考其筹资策略并使其多元化。

临床资料整合平台细分市场预计将成为预测期内最大的细分市场

所产生的临床资料的复杂性和数量不断增加，增加了对能够有效整合和协调不同资料集的简化解决方案的需求。预计在预测期内，临床资料整合平台部分将占据电子临床解决方案市场的最大份额。临床资料整合平台不仅促进无缝资料互通性，而且还支援临床研究和医疗保健服务中的高阶分析、即时洞察和改进决策。此外，将人工智慧 (AI) 和机器学习 (ML) 技术整合到这些平台中将增强预测分析、个人化医疗和临床试验优化等功能。

智慧型手机领域预计在预测期内复合年增长率最高。

智慧型手机产业预计在预测期内将出现最高的复合年增长率，因为它提供了一个无处不在的平台来存取、收集和传输医疗资料，并有助于推动电子临床解决方案的采用。透过专用的行动应用程序，患者可以轻鬆地远端参与临床试验、报告症状、遵守用药时间表并与医疗保健提供者即时沟通。此外，配备感测器和周边设备的智慧型手机可以收集连续的健康资料，例如心率、活动水平和睡眠模式，从而增加了临床研究资料的丰富性和粒度。将智慧型手机整合到电子临床解决方案中不仅提高了病人参与和资料质量，还提高了临床试验的效率和扩充性。

比例最高的地区：

中国、印度和日本等国家正在经历快速的都市化和医疗基础设施的扩张，增加了对先进临床研究技术的需求，以满足其迅速增长的人口的医疗需求。该地区的慢性病和感染疾病呈上升趋势，提高了药物开发和交付的高效临床试验和资料管理解决方案的重要性。此外，旨在促进临床研究和创新的积极政府倡议和法规正在推动製药公司、委外研发机构(CRO) 和医疗保健提供者采用电子临床解决方案。

复合年增长率最高的地区：

预计欧洲地区在整个预测期内将保持盈利成长。欧洲强大的基础设施和完善的法律规范使其成为製药公司和临床研究组织 (CRO) 建立最先进实验室的有吸引力的目的地。这些先进的设施使得临床试验能够有效率地进行，包括大量临床资料的收集、分析和管理。此外，高通量筛检、次世代定序和生物标记分析等实验室技术的进步正在促进临床研究和药物开发更精确和个人化的方法。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球电子临床解决方案市场：按产品

  • 临床试验资料管理系统
  • 电子资料收集
  • 随机化和试验供应管理
  • 临床资料整合平台
  • 电子临床实验主文件系统
  • 监管资讯管理解决方案
  • 其他产品

第六章全球电子临床解决方案市场：依交付型态

  • 许可证企业（本地）解决方案
  • 云端基础（SAAS）的解决方案
  • 网页寄存（按需）解决方案
  • 其他型态的提供

第七章全球电子临床解决方案市场：依临床试验阶段

  • 第二阶段
  • 第一阶段
  • 第四阶段
  • 第三阶段

第八章全球电子临床解决方案市场：按用户设备

  • 智慧型手机
  • 桌面
  • 药片
  • 其他用户设备

第九章全球电子临床解决方案市场：按最终用户分类

  • 合约研究组织
  • 製药和生物製药公司
  • 医疗设备製造商
  • 咨询服务公司
  • 医院
  • 其他最终用户

第10章全球电子临床解决方案市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Medidata Solution
  • OmniComm Systems
  • Oracle Corp
  • ERT Clinical
  • CRF Health
  • PAREXEL International
  • IBM Watson Health
  • Dassault Systems
  • Saama Technologies, INC
  • Veeva Systems
Product Code: SMRC25505

According to Stratistics MRC, the Global eClinical Solutions Market is accounted for $9.5 billion in 2023 and is expected to reach $25.6 billion by 2030 growing at a CAGR of 15.2% during the forecast period. Clinical research is intended to be revolutionized by e-clinical solutions. In order to treat patients more promptly, the clinical management organization is working to enhance the clinical research data's efficacy, efficiency, and accessibility. The goal of developing e-clinical solutions was to identify the issues with clinical research data, provide innovative fixes, and make clinical trial data easily accessible and valuable. It also aimed to streamline the standardization, reporting, and functioning of the clinical research area.

According to ClinicalTrials.gov, as of March 2023, 443,933 studies were listed in 221 countries, out of which 342,633 were interventional studies and 99,578 observational studies. According to the data updated by the National Institute of Health in March 2023, the estimated research funding for clinical trials and supportive activities in the United States in 2022 was USD 6.6 billion, and it is expected to rise to USD 6.8 billion in 2023.

Market Dynamics:

Driver:

Growing adoption of electronic health records

EHRs provide a centralized repository of patient health information, offering valuable data that can be leveraged for clinical research purposes. eClinical solutions that integrate seamlessly with EHR systems enable efficient data collection, patient recruitment, and monitoring throughout the clinical trial lifecycle. By bridging the gap between clinical care and research, these integrated solutions facilitate access to patient populations, accelerate study start-up timelines, and improve the accuracy and completeness of clinical trial data. Moreover, the ability to extract structured data from EHRs enhances data quality and reduces manual data entry errors, ultimately leading to more efficient and cost-effective clinical trials.

Restraint:

High implementation costs

Implementing eClinical solutions entails substantial upfront investments in software licenses, hardware infrastructure, customization, and staff training. These costs can be prohibitive for organizations operating on constrained budgets, deterring them from embracing eClinical technologies. Ongoing maintenance, support, and subscription fees further contribute to the total cost of ownership, exacerbating financial burdens over time. However, the complexity of eClinical solutions and the need for specialized expertise for implementation and customization also contribute to higher costs.

Opportunity:

Increasing globalization of clinical trials

The increasing globalization of clinical trials serves as a significant driver for the eClinical solutions market, as it necessitates efficient data management and collaboration tools across diverse geographic regions. With clinical trials expanding to encompass a broader range of patient populations and healthcare settings worldwide, eClinical solutions provide centralized platforms for data collection, management, and analysis, facilitating seamless collaboration among global trial sites and stakeholders. Additionally, these solutions enable real-time access to study data, streamlining communication and decision-making processes across international teams.

Threat:

Complex regulatory landscape

Clinical trials are subject to stringent regulations imposed by various regulatory bodies such as the FDA (Food and Drug Administration) in the United States and the EMA (European Medicines Agency) in Europe. Navigating these regulations, which encompass data privacy, security, and reporting standards, requires significant resources, expertise, and time. Compliance with evolving regulatory requirements adds complexity to the implementation and operation of eClinical solutions, as organizations must ensure that their systems meet the latest standards.

Covid-19 Impact:

As clinical trials faced disruptions due to lockdowns and restrictions on in-person interactions, there was a heightened demand for remote monitoring, virtual trials, and digital data capture solutions offered by eClinical platforms. The pandemic underscored the importance of real-time data access and analysis, driving the adoption of eClinical solutions for faster decision-making and regulatory compliance. These disruptions can include delays in the procurement of necessary hardware and software components due to manufacturing slowdowns or interruptions. Moreover, the COVID-19 pandemic has highlighted vulnerabilities in supply chains, prompting companies to reassess and diversify their sourcing strategies.

The clinical data integration platforms segment is expected to be the largest during the forecast period

With the increasing complexity and volume of clinical data generated, there is a growing demand for streamlined solutions that can efficiently consolidate and harmonize disparate datasets. Clinical Data Integration Platforms segment is projected to witness largest share in the eClinical Solutions Market throughout the domination period. Clinical Data Integration Platforms not only facilitate seamless data interoperability but also enable advanced analytics, real-time insights, and improved decision-making in clinical research and healthcare delivery. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) technologies into these platforms enhances their capabilities for predictive analytics, personalized medicine, and clinical trial optimization.

The smart phone segment is expected to have the highest CAGR during the forecast period

Smart Phone segment is expected to have the highest CAGR during the forecast period as it offers a ubiquitous platform for accessing, collecting, and transmitting healthcare data, making them instrumental in driving the adoption of eClinical solutions. Through dedicated mobile applications, patients can conveniently participate in remote clinical trials, report symptoms, adhere to medication schedules, and communicate with healthcare providers in real-time. Moreover, smartphones equipped with sensors and peripherals enable the collection of continuous health data, such as heart rate, activity levels, and sleep patterns, enhancing the richness and granularity of clinical research data. This integration of smartphones into eClinical solutions not only improves patient engagement and data quality but also enhances the efficiency and scalability of clinical trials.

Region with largest share:

Due to the rapid urbanization and expanding healthcare infrastructure across countries like China, India, and Japan are fueling demand for advanced clinical research technologies to support the burgeoning healthcare needs of their populations, Asia Pacific region commanded the largest share of the market over the extrapolated period. The increasing prevalence of chronic diseases and infectious ailments in the region has heightened the importance of efficient clinical trials and data management solutions for drug development and healthcare delivery. Additionally, favorable government initiatives and regulations aimed at promoting clinical research and innovation are encouraging the adoption of eClinical solutions among pharmaceutical companies, contract research organizations (CROs), and healthcare providers.

Region with highest CAGR:

Europe region is poised to hold profitable growth throughout the forecast period. Europe's robust infrastructure and well-established regulatory framework make it an attractive destination for pharmaceutical companies and clinical research organizations (CROs) to set up state-of-the-art laboratories. These advanced facilities enable efficient conduct of clinical trials, including the collection, analysis, and management of vast amounts of clinical data. Moreover, advancements in laboratory technologies, such as high-throughput screening, next-generation sequencing, and biomarker analysis, are facilitating more precise and personalized approaches to clinical research and drug development.

Key players in the market

Some of the key players in eClinical Solutions market include Medidata Solution, OmniComm Systems, Oracle Corp, ERT Clinical, CRF Health, PAREXEL International, IBM Watson Health, Dassault Systems, Saama Technologies, INC and Veeva Systems.

Key Developments:

In December 2023, ObvioHealth launched an innovative eCOA solution, integrating scientific and clinical services with advanced study design technology for robust trial outcomes.

In October 2023, a major provider of life science solutions announced the collaboration with the full-service CRO "Atherion Bioresearch". The strategic partnership aims to enhance the opportunities for organizations to increase and streamline processes, grow, and improve data integrity.

In October 2023, Almac Clinical Technologies announced the partnership with Exostar aiming to assist the risk associated with the intellectual property. According to the collaboration, the organizations will come to provide Federated Authentication Access and Single Sign-On (SSO) to eClinical applications for supporting clinical trials which also includes Interactive Response Technology (IRT).

In October 2023, a healthcare technology organization "Madnet" launched the latest software release having (eConsent) electronic consent capabilities in the iMednet eClinical platform. The launch was designed to generate a cost-effective, simple, and general method to collect and store participants' consent for fulfilling the virtual, hybrid, and decentralized clinical trials.

In June 2023, ICON plc announced the latest release of its Digital Platform, supporting seamless integration of site, sponsor, and patient services with harmonized data delivery. The platform is customizable for various therapeutic areas and study designs, offering end-to-end solutions for patient services in clinical trials, including a user-friendly mobile app, direct data capture for in-home services, eCOA, telehealth visits, eConsent, and digital health technology management.

In June 2023, Syneos Health collaborated with uMotif Limited, leveraging an advanced digital platform that incorporates robust Electronic Clinical Outcome Assessment (eCOA) and Electronic Patient-reported Outcomes (ePRO) capabilities. This partnership aims to accelerate the pace of clinical trials, expediting the delivery of groundbreaking medications to patients more efficiently.

In May 2023, eClinical Solutions LLC. announced the expansion of its machine learning (ML) and artificial intelligence (AI) capabilities within the elluminate IQ offering. Data management teams can take advantage of these cutting-edge ML/AL capabilities to conduct data review more efficiently and scalable.

In April 2023, the Medidata subsidiary of Dassault Systemes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systemes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights will further improve clinical trial productivity. This has aided the business in promoting its offerings across the globe.

In March 2023, Clario has launched a cloud-based Image Viewer tool that helps the Sponsors and CROs to see the images of their clinical trials. Previously, several organizations had to participate in the image transfer procedure to see photos for a clinical trial.

Products Covered:

  • Clinical Trial Data Management Systems
  • Electronic Data Capture
  • Randomization and Trial Supply Management
  • Clinical Data Integration Platforms
  • Electronic Trial Master File Systems
  • Regulatory Information Management Solutions
  • Other Products

Delivery Modes Covered:

  • Licensed Enterprise (On- Premises) Solutions
  • Cloud-Based (SAAS) Solutions
  • Web- hosted (On- demand) Solutions
  • Other Delivery Modes

Clinical Trial Phases Covered:

  • Phase II
  • Phase I
  • Phase IV
  • Phase III

User Devices Covered:

  • Smart Phone
  • Desktop
  • Tablet
  • Other User Devices

End Users Covered:

  • Contract Research Organizations
  • Pharmaceutical and Biopharmaceutical Companies
  • Medical Device Manufacturers
  • Consulting Service Companies
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global eClinical Solutions Market, By Product

  • 5.1 Introduction
  • 5.2 Clinical Trial Data Management Systems
  • 5.3 Electronic Data Capture
  • 5.4 Randomization and Trial Supply Management
  • 5.5 Clinical Data Integration Platforms
  • 5.6 Electronic Trial Master File Systems
  • 5.7 Regulatory Information Management Solutions
  • 5.8 Other Products

6 Global eClinical Solutions Market, By Delivery Mode

  • 6.1 Introduction
  • 6.2 Licensed Enterprise (On- Premises) Solutions
  • 6.3 Cloud-Based (SAAS) Solutions
  • 6.4 Web- hosted (On- demand) Solutions
  • 6.5 Other Delivery Modes

7 Global eClinical Solutions Market, By Clinical Trial Phase

  • 7.1 Introduction
  • 7.2 Phase II
  • 7.3 Phase I
  • 7.4 Phase IV
  • 7.5 Phase III

8 Global eClinical Solutions Market, By User Device

  • 8.1 Introduction
  • 8.2 Smart Phone
  • 8.3 Desktop
  • 8.4 Tablet
  • 8.5 Other User Devices

9 Global eClinical Solutions Market, By End User

  • 9.1 Introduction
  • 9.2 Contract Research Organizations
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
  • 9.4 Medical Device Manufacturers
  • 9.5 Consulting Service Companies
  • 9.6 Hospitals
  • 9.7 Other End Users

10 Global eClinical Solutions Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Medidata Solution
  • 12.2 OmniComm Systems
  • 12.3 Oracle Corp
  • 12.4 ERT Clinical
  • 12.5 CRF Health
  • 12.6 PAREXEL International
  • 12.7 IBM Watson Health
  • 12.8 Dassault Systems
  • 12.9 Saama Technologies, INC
  • 12.10 Veeva Systems

List of Tables

  • Table 1 Global eClinical Solutions Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global eClinical Solutions Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global eClinical Solutions Market Outlook, By Clinical Trial Data Management Systems (2021-2030) ($MN)
  • Table 4 Global eClinical Solutions Market Outlook, By Electronic Data Capture (2021-2030) ($MN)
  • Table 5 Global eClinical Solutions Market Outlook, By Randomization and Trial Supply Management (2021-2030) ($MN)
  • Table 6 Global eClinical Solutions Market Outlook, By Clinical Data Integration Platforms (2021-2030) ($MN)
  • Table 7 Global eClinical Solutions Market Outlook, By Electronic Trial Master File Systems (2021-2030) ($MN)
  • Table 8 Global eClinical Solutions Market Outlook, By Regulatory Information Management Solutions (2021-2030) ($MN)
  • Table 9 Global eClinical Solutions Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 10 Global eClinical Solutions Market Outlook, By Delivery Mode (2021-2030) ($MN)
  • Table 11 Global eClinical Solutions Market Outlook, By Licensed Enterprise (On- Premises) Solutions (2021-2030) ($MN)
  • Table 12 Global eClinical Solutions Market Outlook, By Cloud-Based (SAAS) Solutions (2021-2030) ($MN)
  • Table 13 Global eClinical Solutions Market Outlook, By Web- hosted (On- demand) Solutions (2021-2030) ($MN)
  • Table 14 Global eClinical Solutions Market Outlook, By Other Delivery Modes (2021-2030) ($MN)
  • Table 15 Global eClinical Solutions Market Outlook, By Clinical Trial Phase (2021-2030) ($MN)
  • Table 16 Global eClinical Solutions Market Outlook, By Phase II (2021-2030) ($MN)
  • Table 17 Global eClinical Solutions Market Outlook, By Phase I (2021-2030) ($MN)
  • Table 18 Global eClinical Solutions Market Outlook, By Phase IV (2021-2030) ($MN)
  • Table 19 Global eClinical Solutions Market Outlook, By Phase III (2021-2030) ($MN)
  • Table 20 Global eClinical Solutions Market Outlook, By User Device (2021-2030) ($MN)
  • Table 21 Global eClinical Solutions Market Outlook, By Smart Phone (2021-2030) ($MN)
  • Table 22 Global eClinical Solutions Market Outlook, By Desktop (2021-2030) ($MN)
  • Table 23 Global eClinical Solutions Market Outlook, By Tablet (2021-2030) ($MN)
  • Table 24 Global eClinical Solutions Market Outlook, By Other User Devices (2021-2030) ($MN)
  • Table 25 Global eClinical Solutions Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global eClinical Solutions Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 27 Global eClinical Solutions Market Outlook, By Pharmaceutical and Biopharmaceutical Companies (2021-2030) ($MN)
  • Table 28 Global eClinical Solutions Market Outlook, By Medical Device Manufacturers (2021-2030) ($MN)
  • Table 29 Global eClinical Solutions Market Outlook, By Consulting Service Companies (2021-2030) ($MN)
  • Table 30 Global eClinical Solutions Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 31 Global eClinical Solutions Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.